Rock Ventures Iii L.P. Third's Net Worth
Rock Ventures Iii L.P. Third's net worth is estimated to be at least $165,654,131.28 as of 12/23/2024. CoreStreet's estimation of Rock Ventures Iii L.P. Third's net worth is based on their sale of stock and current holding of stock.
Rock Ventures Iii L.P. Third is Major Shareholder at Voyager Therapeutics Inc. They have executed at least 13 trades of stock as per SEC Form 4 filings. Their most recent trade was for 128,642 units of VYGR stock on 02/01/2023. Their biggest sale was on 01/14/2021 when they sold 1,965,294 units of Relay Therapeutics Inc stock for $80,577,054.00. They typically trade 3 times per year.
Total value of insider buys:
- $1,090,171.20
Total value of insider sells:
- $164,563,960.08
Most recent insider trade:
- Feb. 1, 2023
Rock Ventures Iii L.P. Third's Insider Trading History
| Voyager Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 1, 2023 | Major Shareholder | 128,642 | $9.32 | Sell | $1,198,943.44 |
Jan. 30, 2023 | Major Shareholder | 75,000 | $9.03 | Sell | $677,250.00 |
Jan. 27, 2023 | Major Shareholder | 50,000 | $9.02 | Sell | $451,000.00 |
Jan. 25, 2023 | Major Shareholder | 50,000 | $9.22 | Sell | $461,000.00 |
Jan. 23, 2023 | Major Shareholder | 55,000 | $9.06 | Sell | $498,300.00 |
Jan. 20, 2023 | Major Shareholder | 100,000 | $9.15 | Sell | $915,000.00 |
Aug. 24, 2022 | Major Shareholder | 149,972 | $6.09 | Sell | $913,329.48 |
Aug. 15, 2022 | Major Shareholder | 135,808 | $6.04 | Sell | $820,280.32 |
Aug. 12, 2022 | Major Shareholder | 348,007 | $6.12 | Sell | $2,129,802.84 |
| Jounce Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 12, 2021 | Major Shareholder | 1,900,000 | $8.38 | Sell | $15,922,000.00 |
| Relay Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 14, 2021 | Major Shareholder | 1,965,294 | $41.00 | Sell | $80,577,054.00 |
Jan. 12, 2021 | Major Shareholder | 1,500,000 | $40.00 | Sell | $60,000,000.00 |
| Fulcrum Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 19, 2019 | Director | 61,280 | $17.79 | Buy | $1,090,171.20 |